Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Brianna M. Byllesby, Alison M. Haney & Octaviana Hemmy Asamsama. (2023) Emotion Dysregulation and Substance Use Risk and Protective Factors among Veterans in Residential Treatment. Substance Use & Misuse 58:7, pages 930-938.
Read now
Read now
Rachel K. Landis, Jonathan S. Levin, Brendan Saloner, Adam J. Gordon, Andrew W. Dick, Tisamarie B. Sherry, Douglas L. Leslie, Mark Sorbero & Bradley D. Stein. (2022) Sociodemographic differences in quality of treatment to Medicaid enrollees receiving buprenorphine. Substance Abuse 43:1, pages 1057-1071.
Read now
Read now
Sarah E. Wakeman, Martha Kane, Elizabeth Powell, Sydney Howard, Christopher Shaw, Laura Kehoe, Joy Rosen, Joan Quinlan & Susan Regan. (2021) A hospital-wide initiative to redesign substance use disorder care: Impact on pharmacotherapy initiation. Substance Abuse 42:4, pages 767-774.
Read now
Read now
Brendan Saloner, Barbara Andraka Christou, Adam J. Gordon & Bradley D. Stein. (2021) It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver. Substance Abuse 42:2, pages 153-157.
Read now
Read now
Adam J. Gordon, Karen Drexler, Eric J. Hawkins, Jennifer Burden, Nodira K. Codell, Amy Mhatre-Owens, Matthew T. Dungan & Hildi Hagedorn. (2020) Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities. Substance Abuse 41:3, pages 275-282.
Read now
Read now
Ajay Manhapra, Elina Stefanovics & Robert Rosenheck. (2020) Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?. Substance Abuse 41:1, pages 110-120.
Read now
Read now
Bradley D. Stein, Andrew W. Dick, Mark Sorbero, Adam J. Gordon, Rachel M. Burns, Douglas L. Leslie & Rosalie Liccardo Pacula. (2018) A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees. Substance Abuse 39:4, pages 419-425.
Read now
Read now
Joseph W. Frank, Sarah E. Wakeman & Adam J. Gordon. (2018) No end to the crisis without an end to the waiver. Substance Abuse 39:3, pages 263-265.
Read now
Read now
Helen Valenstein-Mah, Hildi Hagedorn, Chad L. Kay, Melissa L. Christopher & Adam J. Gordon. (2018) Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration. Substance Abuse 39:3, pages 286-288.
Read now
Read now
Jessica J. Wyse$suffix/text()$suffix/text(), Adam J. Gordon$suffix/text()$suffix/text(), Steven K. Dobscha$suffix/text()$suffix/text(), Benjamin J. Morasco$suffix/text()$suffix/text(), Elizabeth Tiffany$suffix/text()$suffix/text(), Karen Drexler$suffix/text()$suffix/text(), Friedhelm Sandbrink & Travis I. Lovejoy. (2018) Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps. Substance Abuse 39:2, pages 139-144.
Read now
Read now
Brian Shiner, Christine Leonard Westgate, Nancy C. Bernardy, Paula P. Schnurr & Bradley V. Watts. (2017) Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder. Journal of Dual Diagnosis 13:3, pages 201-212.
Read now
Read now
Matthew Tierney, Deborah S. Finnell, Madeline A. Naegle, Colleen LaBelle & Adam J. Gordon. (2015) Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers. Substance Abuse 36:4, pages 389-392.
Read now
Read now
Warren Harlow, Marian W. Roman, Brenda Happell & Graeme Browne. (2013) Accessibility Versus Quality of Care Plus Retention: The Formula for Service Delivery in Australian Opioid Replacement Therapy?. Issues in Mental Health Nursing 34:9, pages 706-714.
Read now
Read now
Articles from other publishers (33)
Adam J. Gordon, Andrew J. Saxon, Stefan Kertesz, Jessica J. Wyse, Ajay Manhapra, Lewei A. Lin, Wei Chen, Jared Hansen, Derek Pinnell, Tina Huynh, Jacob D. Baylis, Francesca E. Cunningham, Udi E. Ghitza, Gavin Bart, Hong Yu & Brian C. Sauer. (2023) Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug and Alcohol Dependence 248, pages 109902.
Crossref
Crossref
Megan S. Schuler, Brendan Saloner, Adam J. Gordon, Andrew W. Dick & Bradley D. Stein. (2023) National Trends in Buprenorphine Treatment for Opioid Use Disorder From 2007 to 2018. Substance Abuse, pages 088970772311795.
Crossref
Crossref
Saeed Shoja Shafti. (2022) Methadone Contrasted with Acetaminophen Codeine Plus Clonidine: An
Inpatient Pilot Study. Current Psychopharmacology 11:1, pages 43-49.
Crossref
Crossref
Ashley O. Radmall, Spencer Calder, Nodira Codell, Alan Taylor Kelley, Eric Hawkins, Audrey L. Jones, Hildi J. Hagedorn, Mary Anne Reynolds & Adam J. Gordon. (2022) Roles and Perceptions of Nurses During Implementation of a Medication Treatment for Opioid Use Disorder National Initiative. Journal of Addictions Nursing 33:2, pages 70-79.
Crossref
Crossref
Adam J. Gordon, Marie Kenny, Matthew Dungan, Allison M. Gustavson, A. Taylor Kelley, Audrey L. Jones, Eric Hawkins, Joseph W. Frank, Anissa Danner, Joseph Liberto & Hildi Hagedorn. (2022) Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings. The American Journal on Addictions 31:2, pages 152-158.
Crossref
Crossref
Amy J. Kennedy, Kathleen A. McGinnis, Jessica S. Merlin, E. Jennifer Edelman, Adam J. Gordon, P. Todd Korthuis, Melissa Skanderson, Emily C. Williams, Jessica Wyse, Benjamin Oldfield, Kendall Bryant, Amy Justice, David A. Fiellin & Kevin L. Kraemer. (2022) Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. Journal of Substance Abuse Treatment 132, pages 108509.
Crossref
Crossref
Matthew R. Filteau, Brandn Green & Kristal Jones. (2021) Barriers to Community Treatment for Opioid Use Disorders among Rural Veterans. Journal of Veterans Studies 7:3, pages 83.
Crossref
Crossref
Megan S. Schuler, Andrew W. Dick & Bradley D. Stein. (2021) Growing racial/ethnic disparities in buprenorphine distribution in the United States, 2007-2017. Drug and Alcohol Dependence 223, pages 108710.
Crossref
Crossref
Carlos Blanco, Mir M. Ali, Aaron Beswick, Karen Drexler, Cheri Hoffman, Christopher M. Jones, Tisha R. A. Wiley & Allan Coukell. (2020) The American Opioid Epidemic in Special Populations: Five Examples. NAM Perspectives.
Crossref
Crossref
Jennifer Jones, Matthew Tierney, Gabrielle Jacobs, Shao-Yun Chien & Sandra Mallisham. (2020) Empowering Psychiatric Mental Health Nurse Practitioners to Expand Treatment Opportunities for Veterans With Opioid Use Disorder. Journal of Addictions Nursing 31:4, pages 261-268.
Crossref
Crossref
Kelsey C. Priest, Travis I. Lovejoy, Honora Englander, Sarah Shull & Dennis McCarty. (2020) Opioid Agonist Therapy During Hospitalization Within the Veterans Health Administration: a Pragmatic Retrospective Cohort Analysis. Journal of General Internal Medicine 35:8, pages 2365-2374.
Crossref
Crossref
Julian A. Mitton, Sean Jackson, J. Janet Ho & Matthew Tobey. (2020) Opioid and Amphetamine Treatment Trends Among American Indians in the Great Plains. Journal of Addiction Medicine 14:4, pages e100-e102.
Crossref
Crossref
Utibe R. Essien, Florentina E. Sileanu, Xinhua Zhao, Jane M. Liebschutz, Carolyn T. Thorpe, Chester B. Good, Maria K. Mor, Thomas R. Radomski, Leslie R. M. Hausmann, Michael J. Fine & Walid F. Gellad. (2020) Racial/Ethnic Differences in the Medical Treatment of Opioid Use Disorders Within the VA Healthcare System Following Non-Fatal Opioid Overdose. Journal of General Internal Medicine 35:5, pages 1537-1544.
Crossref
Crossref
Denise M. Boudreau, Gwen Lapham, Eric A. Johnson, Jennifer F. Bobb, Abigail G. Matthews, Jennifer McCormack, David Liu, Cynthia I. Campbell, Rebecca C. Rossom, Ingrid A. Binswanger, Bobbi Jo Yarborough, Julia H. Arnsten, Chinazo O. Cunningham, Joseph E. Glass, Mark T. Murphy, Mohammad Zare, Rulin C. Hechter, Brian Ahmedani, Jordan M. Braciszewski, Viviana E. Horigian, José Szapocznik, Jeffrey H. Samet, Andrew J. Saxon, Robert P. Schwartz & Katharine A. Bradley. (2020) Documented opioid use disorder and its treatment in primary care patients across six U.S. health systems. Journal of Substance Abuse Treatment 112, pages 41-48.
Crossref
Crossref
Gwen Lapham, Denise M. Boudreau, Eric A. Johnson, Jennifer F. Bobb, Abigail G. Matthews, Jennifer McCormack, David Liu, Jeffrey H. Samet, Andrew J. Saxon, Cynthia I. Campbell, Joseph E. Glass, Rebecca C. Rossom, Mark T. Murphy, Ingrid A. Binswanger, Bobbi Jo H. Yarborough, Katharine A. Bradley, Brian Ahmedani, Paul J. Amoroso, Julia H. Arnsten, Gavin Bart, Jordan M. Braciszewski, Chinazo O. Cunningham, Rulin C. Hechter, Viviana E. Horigian, Jane M. Liebschutz, Amy M. Loree, Theresa E. Matson, Jennifer McNeely, Joseph O. Merrill, Thomas F. Northrup, Robert P. Schwartz, Angela L. Stotts, José Szapocznik, Manu Thakral, Judith I. Tsui & Mohammad Zare. (2020) Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug and Alcohol Dependence 207, pages 107732.
Crossref
Crossref
Kevin L. Kraemer, Kathleen A. McGinnis, David A. Fiellin, Melissa Skanderson, Adam J. Gordon, Jonathan Robbins, Susan Zickmund, Kendall Bryant & P. Todd Korthuis. (2019) Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans. Journal of Substance Abuse Treatment 103, pages 23-32.
Crossref
Crossref
Jessica J. Wyse, Jonathan L. Robbins, Kathleen A. McGinnis, E. Jennifer Edelman, Adam J. Gordon, Ajay Manhapra, David A. Fiellin, Brent A. Moore, P. Todd Korthuis, Julie R. Gaither, Kirsha Gordon, Melissa Skanderson, Declan T. Barry, Stephen Crystal, Amy Justice & Kevin L. Kraemer. (2019) Predictors of timely opioid agonist treatment initiation among veterans with and without HIV. Drug and Alcohol Dependence 198, pages 70-75.
Crossref
Crossref
Andrea K. Finlay, Ingrid A. Binswanger, Christine Timko, David Smelson, Matthew A. Stimmel, Mengfei Yu, Tom Bowe & Alex H.S. Harris. (2018) Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of Substance Abuse Treatment 95, pages 43-47.
Crossref
Crossref
Grace Chang, Mitchell Crawford, Michelle Pitts, Abigail Z. Schein, Katherine Goodwin & Justin L. Enggasser. (2018) Adherence to extended release naltrexone: Patient and treatment characteristics. The American Journal on Addictions 27:6, pages 524-530.
Crossref
Crossref
Benjamin J Oldfield, Ellen L Edens, Alicia Agnoli, Curtis W Bone, Dana J Cervone, Sara N Edmond, Ajay Manhapra, John J Sellinger & William C Becker. (2018) Multimodal Treatment Options, Including Rotating to Buprenorphine, Within a Multidisciplinary Pain Clinic for Patients on Risky Opioid Regimens: A Quality Improvement Study. Pain Medicine 19:suppl_1, pages S38-S45.
Crossref
Crossref
Jack Tsai & Robert A Rosenheck. (2018) Characteristics and Health Needs of Veterans with Other-than-Honorable Discharges: Expanding Eligibility in the Veterans Health Administration. Military Medicine 183:5-6, pages e153-e157.
Crossref
Crossref
H. Hayden Barmada, Dustin Patil, Sarah P. Roberts, Hector A. Colon-Rivera & Grace Chang. (2018) Perceived Stigma and Satisfaction With Care Among Veterans Receiving Methadone Maintenance Treatment: A Pilot Study. Addictive Disorders & Their Treatment 17:1, pages 21-28.
Crossref
Crossref
John F. Kelly, Brandon Bergman, Bettina B. Hoeppner, Corrie Vilsaint & William L. White. (2017) Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug and Alcohol Dependence 181, pages 162-169.
Crossref
Crossref
Noa Krawczyk, Kenneth A. Feder, Michael I. Fingerhood & Brendan Saloner. (2017) Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample. Drug and Alcohol Dependence 178, pages 512-518.
Crossref
Crossref
Joseph K. Eibl, Graham Gauthier, David Pellegrini, Jeffery Daiter, Michael Varenbut, John C. Hogenbirk & David C. Marsh. (2017) The effectiveness of telemedicine-delivered opioid agonist therapy in a supervised clinical setting. Drug and Alcohol Dependence 176, pages 133-138.
Crossref
Crossref
Stephanie Lee Peglow, Ismene Petrakis & Robert Rosenheck. (2017) Opioid agonist treatment in the Veterans Health Administration: is health care local?. Journal of Public Mental Health 16:1, pages 28-36.
Crossref
Crossref
Adam Gordon, Wei-Hsuan Lo-Ciganic, Gerald Cochran, Walid F. Gellad, Terri Cathers & Julie M. Donohue. (2016) Treatment Quality for Buprenorphine Care. Journal of Addiction Medicine 10:3, pages 210-211.
Crossref
Crossref
Andrea K. Finlay, David Smelson, Leon Sawh, Jim McGuire, Joel Rosenthal, Jessica Blue-Howells, Christine Timko, Ingrid Binswanger, Susan M. Frayne, Janet C. Blodgett, Tom Bowe, Sean C. Clark & Alex H. S. Harris. (2014) U.S. Department of Veterans Affairs Veterans Justice Outreach Program. Criminal Justice Policy Review 27:2, pages 203-222.
Crossref
Crossref
Ajay Manhapra, Lantie Quinones & Robert Rosenheck. (2016) Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration. Drug and Alcohol Dependence 160, pages 82-89.
Crossref
Crossref
Anna D. Rubinsky, Cheng Chen, Steven L. Batki, Emily C. Williams & Alex H.S. Harris. (2015) Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses. Journal of Psychiatric Research 69, pages 150-157.
Crossref
Crossref
BRADLEY D. STEIN, ROSALIE LICCARDO PACULA, ADAM J. GORDON, RACHEL M. BURNS, DOUGLAS L. LESLIE, MARK J. SORBERO, SEBASTIAN BAUHOFF, TODD W. MANDELL & ANDREW W. DICK. (2015) Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties. Milbank Quarterly 93:3, pages 561-583.
Crossref
Crossref
Andrew W. DickRosalie L. PaculaAdam J. GordonMark SorberoRachel M. BurnsDouglas LeslieBradley D. Stein. (2015) Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11. Health Affairs 34:6, pages 1028-1034.
Crossref
Crossref
AAJ Research. (2018) Fighting for Those Who Fight for Us: Protecting the Rights of Servicemembers and Veterans. SSRN Electronic Journal.
Crossref
Crossref